Delivery Order SPE2D024D0002-SPE2D325F464T
- Not listed
- The U.S. Medical Supply Chain awarded a delivery order to Prasco, LLC on July 2, 2025, for the supply of Atovaquone-Proguanil 250-100 tablets (100 count) with a ceiling value of $3,981.04. This contract utilizes a firm fixed price structure with no set-aside designation and requires completion by July 3, 2025. The award is to be fulfilled at Prasco's facilities in Mason, Ohio, where the pharmaceutical manufacturer is headquartered. This delivery order falls under one of Prasco's two...
- The U.S. Medical Supply Chain awarded a delivery order valued at $4,549.76 to Prasco, LLC on August 7, 2025, for the procurement of Atovaquone-Proguanil 250-100mg tablets in quantities of 100 units. This contract, with a firm fixed price structure and an ultimate completion date of August 8, 2025, carries no set-aside designation. Prasco, a pharmaceutical manufacturer headquartered in Mason, Ohio, will perform the work at its location in Mason, OH 45040. The Medical Supply Chain, which...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Atovaquone-Proguanil 250-100 mg tablets in a quantity of 100 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,678.95 and is scheduled for completion by June 25, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets in a quantity of 100 units. This is a firm fixed-price delivery order valued at $10,073.70 with an ultimate completion date of August 15, 2025. The contract is not set-aside and was competitively awarded. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, the corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count) with a firm fixed price ceiling value of $6,788.82. This contract, which is not set-aside and represents a competitive award, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. The delivery order utilizes AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,469.83 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Atovaquone-Proguanil 250-100mg in 100-count units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, performed at the contractor's facility in Conshohocken, Pennsylvania. The antimalarial medication delivery supports federal medical procurement requirements, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,357.43 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 tablets), a antimalarial pharmaceutical commonly used for malaria prevention and treatment in military personnel. The contract was executed on July 14, 2025, with an ultimate completion date of July 15, 2025, and represents a firm fixed-price, non-set-aside competitive award. Performance will be fulfilled from the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,217.11 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 tablets), with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication commonly prescribed for malaria prophylaxis and treatment,...
- The Defense Logistics Agency awarded a $24,468 delivery order to AmerisourceBergen Drug Corp on December 5, 2024, for the supply of Atovaquone-Proguanil 250-100 tablets in quantities of 100, with an ultimate completion date of December 6, 2024. This contract represents a firm fixed price, competitively awarded delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication commonly used for...
- The Defense Logistics Agency awarded a delivery order valued at $9,402.12 to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Atovaquone-Proguanil 250-100 mg tablets (100 count). This is a firm fixed-price, non-set-aside competitive award with a completion date of May 7, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication commonly used for malaria prophylaxis and treatment,...
- SPE2D024D0002Indefinite Delivery Contract
- SPE2D024D0002-SPE2D325F464TDelivery Order
The U.S. Medical Supply Chain awarded a delivery order to Prasco, LLC on September 29, 2025, for the procurement of Atovaquone-Proguanil 250-100mg tablets in quantities of 100 units. The contract is valued at $2,843.60 under a firm fixed-price arrangement with a completion deadline of September 30, 2025. This delivery order carries no set-aside designation and will be performed at Prasco's manufacturing and distribution facility in Mason, Ohio. Atovaquone-proguanil is an antimalarial medication commonly used for malaria prevention and treatment, supporting federal health security and disease prevention initiatives. This award represents a task order placed under one of Prasco's existing Indefinite Delivery Contracts with the Medical Supply Chain, a significant pharmaceutical supply relationship valued at $31.7 billion through June 2034. Prasco, a for-profit pharmaceutical company headquartered in Mason, Ohio, has been registered as a federal contractor since October 2012 and maintains a strong track record supplying critical medications and medical products to federal agencies including the Department of Veterans Affairs and Centers for Disease Control and Prevention. The firm's extensive pharmaceutical portfolio and established IDV vehicles position it as a key supplier for federal healthcare procurement across multiple agencies and programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/29/25 |